[LRMR] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
08-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -47.58%
YoY- -158.51%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -21,627 -8,366 -8,667 -12,609 -11,330 -3,704 -15,775 5.39%
Tax 0 -46 -20 0 -32 -8,482 0 -
NP -21,627 -8,366 -8,647 -12,609 -11,330 -3,704 -15,775 5.39%
Tax Rate - - - - - - - -
Total Cost 21,627 8,366 8,647 12,609 11,330 3,704 15,775 5.39%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.34 -0.19 -0.47 -0.79 -1.21 -0.40 -5.72 -37.50%
EPS Diluted -0.34 -0.19 -0.47 -0.79 -1.21 -0.40 -5.72 -37.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.